Flucytosine
Who holds supplier records for Flucytosine? 7 organisations hold a current record for Flucytosine: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (1) and Switzerland (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Flucytosine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/flucytosine
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Flucytosine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Calyx Chemicals & Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 23503 · latest filing Jan 2010
- Maithri Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 31959 · latest filing Aug 2017
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 28247 · latest filing Jun 2014
- NANTONG JINGHUA PHARMACEUTICAL CO LTDChinaCEPActive DMF 25094 · latest filing Jul 2011
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 37631 · latest filing Nov 2022
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 32090 · latest filing Nov 2017
- SwitzerlandCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Flucytosine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2020-423 - Rev 02 Flucytosine | Oct 2025 | — |
| DSM-FIRMENICH SWITZERLAND AG Kaiseraugst | CH | CEP 2009-091 - Rev 02 Flucytosine | Jul 2025 | — |
| MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village | IN | CEP 2018-011 - Rev 04 Flucytosine | Oct 2024 | — |
| CALYX CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2016-019 - Rev 00 Flucytosine | Jul 2023 | — |
| NANTONG JINGHUA PHARMACEUTICAL CO., LTD. Nantong | CN | R1-CEP 2016-161 - Rev 00 Flucytosine | Jul 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Flucytosine are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- United States · Inactive DMF 15476 · filed Jun 2001
Overview
Flucytosine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1463).
Chemical identity
- IUPAC name
- 6-amino-5-fluoro-1H-pyrimidin-2-one
- Canonical SMILES
- C1=NC(=O)NC(=C1F)N
- InChIKey
- XRECTZIEBJDKEO-UHFFFAOYSA-N
- Synonyms
- Alcobon, Ancoban, Ancobon, Ancotil, Flourocytosine, Flucitosina, Flucytosine, Flucytosinum, Fluorocytosine, NSC-103805, RO 2-9915, RO-2-9915
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nucleoside Analog Antifungal
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Flucytosine?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Flucytosine: Calyx Chemicals & Pharmaceuticals Ltd. (India), Maithri Laboratories Private Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), NANTONG JINGHUA PHARMACEUTICAL CO LTD (China), Laurus Labs Limited (India), SOLARA ACTIVE PHARMA SCIENCES LTD (India) and DSM-FIRMENICH SWITZERLAND AG (Switzerland). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Flucytosine Drug Master Files are active?
Calyx Chemicals & Pharmaceuticals Ltd. (DMF 23503), Maithri Laboratories Private Limited (DMF 31959), MATRIX PHARMACORP PRIVATE LTD (DMF 28247), NANTONG JINGHUA PHARMACEUTICAL CO LTD (DMF 25094), Laurus Labs Limited (DMF 37631) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 32090). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Flucytosine records mean?
1 organisation has only inactive Type II DMFs for Flucytosine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Flucytosine have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Flucytosine on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), DSM-FIRMENICH SWITZERLAND AG Kaiseraugst (CH), MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN), CALYX CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai (IN) and NANTONG JINGHUA PHARMACEUTICAL CO., LTD. Nantong (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Flucytosine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Flucytosine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.